DIURNAL GROUP
Diurnal is an innovative pharmaceutical company that creates high-value therapeutics using advanced proprietary formulations and novel physiological treatment regimes of approved drugs for use in the endocrine (hormone) area. Founded in 2004, Diurnal is headquartered in Cardiff, United Kingdom, and is a specialty pharma company developing hormone therapeutics for the global market for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, and hypogonadism. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.
DIURNAL GROUP
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2004-01-01
Address:
Cardiff, Cardiff, United Kingdom
Country:
United Kingdom
Website Url:
http://www.diurnal.co.uk
Total Employee:
11+
Status:
Active
Contact:
+441142755569
Email Addresses:
[email protected]
Total Funding:
56.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Domain Not Resolving
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Current Employees Featured
Founder
Stock Details
Investors List
IP Group
IP Group investment in Venture Round - Diurnal Group
Fusion IP
Fusion IP investment in Venture Round - Diurnal Group
Fusion IP
Fusion IP investment in Debt Financing - Diurnal Group
Development Bank of Wales
Development Bank of Wales investment in Grant - Diurnal Group
Fusion IP
Fusion IP investment in Grant - Diurnal Group
Viking Fund
Viking Fund investment in Grant - Diurnal Group
Official Site Inspections
http://www.diurnal.co.uk Semrush global rank: 1.06 M Semrush visits lastest month: 31.38 K
- Host name: 52.14.198.104.bc.googleusercontent.com
- IP address: 104.198.14.52
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Diurnal Group"
Diurnal is now Neurocrine UK
Neurocrine Group Ltd (Company Number: 09846650) and its subsidiary, Neurocrine UK Ltd (Company Number: 05237326) are companies registered in England and Wales. Registered โฆSee details»
Home | Diurnal | Dedicated to developing hormone therapeutics
Diurnal is a European, UK-headquartered specialty pharmaceutical company dedicated to developing lifelong treatments for rare and chronic endocrine conditions. ... You are leaving . โฆSee details»
Home | Diurnal
Diurnal Group PLC (Company Number: 09846650) and its subsidiary, Diurnal Limited (Company Number: 05237326), are companies registered in England and Wales. Registered Offices: โฆSee details»
Diurnal Group - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +441142755569 Diurnal is an innovative pharmaceutical company that creates high-value therapeutics using advanced proprietary โฆSee details»
Contact us | UK Residents | HCP | Neurocrine UK - Diurnal
Diurnal is now Neurocrine UK. Home; Contact us; Products. Alkindi® (Hydrocortisone Granules In Capsules For Opening) Efmody® (hydrocortisone modified-release hard capsules) ...See details»
Neurocrine doles out £48M to acquire small UK โฆ
Aug 30, 2022 Neurocrine Biosciences shelled out 48.3 million pounds sterling (approximately $56.5 million) to buy London-based Diurnal Group, the company disclosed in a securities filing. Nuerocrine, a company ...See details»
Contact us | Non-UK Residents | HCP | Neurocrine UK | Our
Neurocrine Group Ltd (Company Number: 09846650) and its subsidiary, Neurocrine UK Ltd (Company Number: 05237326) are companies registered in England and Wales. Registered โฆSee details»
Company Information - RocketReach
Founded in 2004, DIURNAL®, a NEUROCRINE BIOSCIENCES® Company, is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone โฆSee details»
Neurocrine Bio agrees $57m takeover of UK biotech โฆ
Aug 30, 2022 The 27.5 pence-a-share cash deal values Diurnal at around £48.3 million ($57 million), a 144% premium to the biotech's closing share price on Friday. Shares in the UK firm had leaped 132% to 26.1 ...See details»
Diurnal Group plc - AnnualReports.com
Diurnal Group plc operates as a specialty pharma company worldwide. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, โฆSee details»
Diurnal - LinkedIn
Diurnal | 310 followers on LinkedIn. A Neurocrine Biosciences Company | Founded in 2004, DIURNAL®, a NEUROCRINE BIOSCIENCES® Company, is a European, UK-headquartered โฆSee details»
Our patient first approach - annualreports.co.uk
A UK-based, patient-focused specialty pharma company developing high-quality products for the life-long treatment of chronic endocrine conditions. STRATEGIC REPORT 1 Highlights 2 โฆSee details»
Neurocrine Biosciences Buys UK-Based Hormone Therapy Player
Aug 30, 2022 Neurocrine Biosciences Inc (NASDAQ: NBIX) has agreed to pay £48.3 million for the U.K. hormone therapy group, Diurnal Group Plc. The 27.5p share offered represents a โฆSee details»
Results for the year ended 30 June 2019 - diurnal.com
Jun 30, 2019 About Us. Founded in 2004, DIURNAL ®, a NEUROCRINE BIOSCIENCES ® Company, is a European, UK-headquartered specialty pharmaceutical company dedicated to โฆSee details»
Adrenal Insufficiency | UK Residents | HCP - Diurnal
Products. Founded in 2004, DIURNAL ®, a NEUROCRINE BIOSCIENCES ® Company, is a European, UK-headquartered specialty pharmaceutical company dedicated to developing โฆSee details»
Diurnal - Definition, Usage & Quiz | UltimateLexicon.com
Diurnal: Definition, Etymology, and Comprehensive Insight Definition. Diurnal refers to organisms or activities that occur during the daytime. The term is used to describe patterns and behaviors โฆSee details»
'Youth Hostels are unlike anything else in the UK - The Mirror
1 day ago There are more than 150 Youth Hostel Association hostels across England and Wales providing cheap bed and board to many, but the organisation is facing a huge challengeSee details»
Diurnal Temperature: Definition & Causes - StudySmarter
Example of Diurnal Temperature Variation: In a city like Phoenix, Arizona, daytime temperatures can soar to around 40°C (104°F) during summer while nighttime temperatures may plummet โฆSee details»
DIURNALไธญๆ(็ฎไฝ)็ฟป่ฏ๏ผๅๆกฅ่ฏๅ ธ - Cambridge Dictionary
Diurnal็ฟป่ฏ๏ผๅจไธๅคฉๅ ๅ็็;็ฝๅคฉๅ็็;ๆผ่กๆง็ใไบ่งฃๆดๅคใSee details»
Alkindi® (Hydrocortisone Granules In Capsules For Opening) | UK ...
Click here to view the UKGB/UKNI Prescribing information. Click here to view the Alkindi administration video. Alkindi ® (hydrocortisone granules in capsules for opening) is indicated โฆSee details»